Taysha Gene Therapies Assets & Liabilities Overview 2020-2023 | TSHA
Taysha Gene Therapies assets & liabilities overview from 2020 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Taysha Gene Therapies Annual Assets & Liabilities Overview (Millions of US $) |
Taysha Gene Therapies Quarterly Assets & Liabilities Overview (Millions of US $) |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Generic Drugs |
$0.447B |
$0.015B |
Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.
|